Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer

Abstract

Folate-conjugated amphiphilic cyclodextrin nanoparticles can be considered as promising Cremophor^®-free, low-toxicity and efficient active drug delivery systems for paclitaxel.